Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 9/23/14 → 9/23/17 |
Funding
- PPD Development (Prot #CC-10004-AD-001 // Prot #CC-10004-AD-001)
- Celgene Corporation (Prot #CC-10004-AD-001 // Prot #CC-10004-AD-001)
Prot #CC-10004-AD-001: A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy and Safety Study of Apremilast (CC-10004) in Subjects with Moderate to Severe Atopic Dermatitis
- Silverberg, Jonathan I (PD/PI)
Project: Research project